Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the long strain of respiratory syncytial virus

Journal of General Virology

Volumn 85, Issue 11, 2004, Pages 3229-3238

  Johnstone, Carolina ^a   de León, Patricia ^a   Medina, Francisco ^a   Melero, José A ^a   García Barreno, Blanca ^a   Del Val, Margarita ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; F ANTIGEN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; FIBROBLAST; GENETIC CONSERVATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MOTIF; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEQUENCE ANALYSIS; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS STRAIN;

AMINO ACID MOTIFS; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON TYPE II; LIGANDS; MICE; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SPECIES SPECIFICITY; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL PROTEINS;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; MURINAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; VACCINIA VIRUS;

EID: 7444235963     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80219-0     Document Type: Article

References (43)

1. + T-cell response is much less apparent following secondary challenge. J Virol 74, 3486-3493.
2. Bembridge, G. P., López, J. A., Cook R., Melero, J. A. & Taylor, G. (1998). Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon. J Virol 72, 4080-4087.
3. Bembridge, G. P., Rodríguez, N., García-Beato, R., Nicolson, C., Melero, J. A. & Taylor, G. (2000). DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation. J Gen Virol 81, 2519-2523.
4. Blasco, R. & Moss, B. (1995). Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158, 157-162.
5. Cannon, M. J., Openshaw, P. J. & Askonas, B. A. (1988). Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 168, 1163-1168.
6. Carbone, F. R. & Bevan, M. J. (1990). Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 171, 377-387.
7. + T-cell memory in the respiratory tract. Nat Med 8, 54-60.
8. + T cells during experimental virus infection. J Immunol 167, 4254-4260.
9. Chen, W., Antón, L. C., Bennink, J. R. & Yewdell, J. W. (2000). Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12, 83-93.
10. Collins, P. L., Chanock, R. M. & Murphy, B. R. (2001). Respiratory syncytial virus. In Fields Virology, 4th edn, pp. 1443-1485. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
11. Cristina, J., López, J. A., Albo, C., García-Barreno, B., García, J., Melero, J. A. & Portela, A. (1990). Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity. Virology 174, 126-134.
12. + T cell immunodominance in primary and secondary influenza virus infections. J Exp Med 198, 399-410.
13. Del Val, M., Volkmer, H., Rothbard, J. B., Jonjić, S., Messerle, M., Schickedanz, J., Reddehase, M. J. & Koszinowski, U. H. (1988). Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J Virol 62 3965-3972.
14. Del Val, M., Schlicht, H. J., Ruppert, T., Reddehase, M. J. & Koszinowski, U. H. (11991). Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66, 1145-1153.
15. Eisenlohr, L. C., Yewdell, J. W. & Bennink, J. R. (1992). Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 175 481-487.
16. Fernie, B. F., Ford, E. C. & Gerin, J. L. (1981). The development of Balb/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface. Proc Soc Exp Biol Med 167, 83-86.
17. Gaddum, R. M., Cook R. S., Wyld, S. G., López, J. A., Bustos, R., Melero, J. A. & Taylor, G. (1996). Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection. J Gen Virol 77, 1239-1248.
18. García-Barreno, B., Jorcano, J. L., Aukenbauer, T., López-Galíndez, C. & Melero, J. A. (1988). Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Res 9, 307-321.
19. García-Barreno, B., Palomo, C., Peñas, C., Delgado, T., Pérez-Breña, P. & Melero, J. A. (1989). Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol 63, 925-932.
20. González-Reyes, L., Ruiz-Argüello, M. B., García-Barreno, B., Calder, L., López, J. A., Albar, J. P., Skehel, J. J., Wiley, D. C. & Melero, J. A. (2001). Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A 98, 9859-9864.
21. Graham, B. S., Bunton, L. A., Wright, P. F. & Karzon, D. T. (1991). Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88, 1026-1033.
22. d-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus. J Gen Virol 83, 429-438.
23. Keşmir, C., Nussbaum, A. K., Schild, H., Detours, V. & Brunak, S. (2002). Prediction of proteasome cleavage motifs by neural networks. Protein Eng 15, 287-296.
24. Kulkarni, A. B., Collins, P. L., Bacik I., Yewdell, J. W., Bennink J. R., Crowe, J. E., Jr & Murphy, B. R. (1995). Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J Virol 69, 1261-1264.
25. Li, X., Sambhara, S., Li, C. X. & 7 other authors (1998). Protection against respiratory syncytial virus infection by DNA immunization. J Exp Med 188, 681-688.
26. López, J. A., Villanueva, N., Melero, J. A. & Portela, A. (1988). Nucleotide sequence of the fusion and phosphoprotein genes of human respiratory syncytial (RS) virus Long strain: evidence of subtype genetic heterogeneity. Virus Res 10, 249-261.
27. López, J. A., Bustos, R., Örvell, C., Berois, M., Arbiza, J., García-Barreno, B. & Melero, J. A. (1998). Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol 72, 6922-6928.
28. Martínez, I., Bustos, J. & Melero, J. A. (2001). Reduced expression of surface glycoproteins in mouse fibroblasts persistently infected with human respiratory syncytial virus (HRSV). Arch Virol 146, 669-683.
29. Nussbaum, A. K., Kuttler, C., Tenzer, S. & Schild, H. (2003). Using the World Wide Web for predicting CTL epitopes. Curr Opin Immunol 15, 69-74.
30. Olmsted, R. A., Elango, N., Prince, G. A., Murphy, B. R., Johnson, P. R., Moss, B., Chanock R. M. & Collins, P. L. (1986). Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A 83, 7462-7466.
31. Parker, K. C., Bednarek, M. A. & Coligan, J. E. (1994). Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152, 163-175.
32. Pemberton, R. M., Cannon, M. J., Openshaw, P. J., Ball, L. A., Wertz, G. W. & Askonas, B. A. (1987). Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J Gen Virol 68, 2177-2182.
33. Rammensee, H. G., Bachmann, J., Emmerich, N. P., Bachor, O. A. & Stevanovic, S. (1999). SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219.
34. Restifo, N. P., Bačík, I., Irvine, K. R., Yewdell, J. W., McCabe, B. J., Anderson, R. W., Eisenlohr, L. C., Rosenberg, S. A. & Bennink, J. R. (1995). Antigen processing in vivo and the elicitation of primary CTL responses. J Immunol 154, 4414-4422.
35. Schlender, J., Zimmer, G., Herrler, G. & Conzelmann, K. K. (2003). Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection. J Virol 77, 4609-4616.
36. Simoes, E. A. (1999). Respiratory syncytial virus infection. Lancet 354, 847-852.
37. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med 186, 421-432.
38. Stott, E. J., Taylor, G., Ball, L. A., Anderson, K., Young, K. K., King, A. M. & Wertz, G. W. (1987). Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J Virol 61, 3855-3861.
39. Taylor, G., Stott, E. J., Bew, M., Fernie, B. F., Cote, P. J., Collins, A. P., Hughes, M. & Jebbett, J. (1984). Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52, 137-142.
40. The IMpact-RSV Study Group (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531-537.
41. Yewdell J. W. & Bennink, J. R. (1999). Immunodominance in major Histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17, 51-88.
42. d in proteasome subunit LMP2- and LMP7-deficient cells. Eur J Immunol 24, 1863-1868.
43. Zimmer, G., Budz, L. & Herrler, G. (2001). Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences. J Biol Chem 276, 31642-31650.